20 May 2013
Keywords: astrazeneca, gerd, drug, improves, asthma, anglo-swedish, pharmaceutical
Article | 30 May 2005
Anglo-Swedish pharmaceutical group AstraZeneca says that adding its gastric proton pump inhibitor Nexium (esomeprazole) to existing treatment schedules improves pulmonary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.